Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13 tissue inhibitor of metalloproteinase 1 expression in murine silicosis

被引:41
|
作者
Ortiz, LA
Lasky, J
Gozal, E
Ruiz, V
Lungarella, G
Cavarra, E
Brody, AR
Friedman, M
Pardo, A
Selman, M
机构
[1] Tulane Univ, Med Ctr, Sect Pulm Dis Crit Care & Environm Med, Dept Pathol, New Orleans, LA 70112 USA
[2] Tulane Univ, Med Ctr, Lung Biol Program, New Orleans, LA 70112 USA
[3] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico
[5] Univ Siena, Ist Patol Gen, I-53100 Siena, Italy
关键词
D O I
10.1164/ajrccm.163.1.2002123
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Murine exposure to silica is associated with enhanced tumor necrosis factor alpha (TNF-alpha) expression and matrix deposition. The regulation of TNF is mediated through TNF receptor (TNFR) activation of transcription factors. In the present work we have studied the importance of the individual TNFR in silica-induced lung inflammation and matrix deposition in mice. We studied RNA expression of TNF, alpha1(I) collagen, interstitial collagenase (MMP-13), and its inhibitor (TIMP-1) in the lungs of silica-treated mice. Furthermore, we correlated MMP-13/TIMP-1 RNA abundance with activation of the transcription factors AP-1 and NF-kappaB in the lungs of C57BL/6 mice, and of mice deficient in one of the two types of TNFR (p55(-/-) or p75(-/-)), exposed to silica (0.2 g/kg) or saline by intratracheal instillation. Animals were killed 28 d after exposure and lung hydroxyproline (HP), TNF, alpha1(I) collagen, MMP-13, and TIMP-1 RNA abundance was measured. AP-1 and NF-kappaB activation was studied by gel-shift assays. Compared with C57BL/6 mice, p55(-/-) and p75(-/-) mice significantly (*p < 0.05) decreased lung HP accumulation in response to silica. All murine strains enhanced TNF and <alpha>1(I) collagen mRNA in response to silica. Enhanced (p < 0.05) MMP-13 RNA expression was also observed in all murine strains in response to silica. Enhanced (p < 0.05) TIMP-1 RNA expression was observed in C57BL/6 mice, but not in p55(-/-) or p75(-/-) mice, in response to silica. NF-KB activation was observed in all murine strains, whereas AP-1 activation was observed only in C57BL/6 mice after silica treatment. These data suggest that TNFR deletion modifies MMP-13/TIMP-1 expression in favor of matrix degradation.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [41] Expression of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1 in nonrecurrent vs recurrent nasal polyps
    Yeo, Nam-Kyung
    Eom, Daeo-Woon
    Oh, Mi Young
    Lim, Hyun Woo
    Song, Yong Jin
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (03) : 205 - 210
  • [42] Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma
    Inoue, H
    Mimori, K
    Shiraishi, T
    Kataoka, A
    Sadanaga, N
    Ueo, H
    Barnard, GF
    Mori, M
    ONCOLOGY REPORTS, 2000, 7 (04) : 871 - 874
  • [43] Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers
    Li, Gongchi
    Zou, Xinhua
    Zhu, Youpeng
    Jing, Zhang
    Zhou, Lijun
    Wang, Dan
    Li, Binghui
    Chen, Zhenbing
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2017, 16 (01): : 6 - 13
  • [44] The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis
    Wereszczynska-Siemiatkowska, U.
    Siemiatkowski, A.
    Swidnicka-Siergiejko, A.
    Mroczko, B.
    Dabrowski, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (03): : 199 - 204
  • [45] Regulation of matrix metalloproteinase MMP-1 in calcific aortic stenosis: Role of inflammation, tumor necrosis factor alpha, and tissue inhibitor of metalloproteinases 1
    Kaden, JJ
    Haase, KK
    Grobholz, R
    Fischer, GS
    Vocke, DC
    Pinol, R
    Antoni, C
    Gaudron, P
    Borggrefe, M
    CIRCULATION, 2001, 104 (17) : 359 - 359
  • [46] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [47] Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients
    Stanciu, Adina Elena
    Zamfir-Chiru-Anton, Adina
    Stanciu, Marcel Marian
    Gherghe, Mirela
    Hainarosie, Razvan
    Furtunescu, Florentina Ligia
    Gheorghe, Dan Cristian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (04)
  • [48] Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents
    Glowinska-Olszewska, Barbara
    Urban, Miroslawa
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (06): : 799 - 805
  • [49] Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer
    Ross, JS
    Kaur, P
    Sheehan, CE
    Fisher, HAG
    Kaufman, RA
    Kallakury, BVS
    MODERN PATHOLOGY, 2003, 16 (03) : 198 - 205
  • [50] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618